Analyst Rating Changes — Upgrades, Downgrades & Price Targets

37152 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.

Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.

All ↑ Upgrades ↓ Downgrades ◎ Price Targets

Latest Price-Target Changes

When	Stock	Change	Firm	Analyst	Rating	Price Target
Oct 08 14:14 UTC	RRX Regal Rexnord	◎ Target	Oppenheimer	Christopher Glynn ★★★★☆ #922	Outperform	$245.00→ $200.00-18.4%
Oct 08 14:14 UTC	REGN Regeneron Pharmaceuticals	◎ Target	Royal Bank Of Canada	Brian Abrahams ★★☆☆☆ #2565	Sec→ r Perform	$737.00→ $810.00+9.9%
Oct 08 14:14 UTC	PATK Patrick Industries	◎ Target	KeyCorp	Noah Zatzkin ★★☆☆☆ #2335	Overweight	$115.00→ $100.00-13.0%
Oct 08 14:14 UTC	OSIS OSI Systems	◎ Target	Oppenheimer	Christopher Glynn ★★★★☆ #922	Outperform	$300.00→ $265.00-11.7%
Oct 08 14:14 UTC	GILD Gilead Sciences	◎ Target	Royal Bank Of Canada	Brian Abrahams ★★☆☆☆ #2565	Sec→ r Perform	$123.00→ $126.00+2.4%
Oct 08 14:14 UTC	GHM Graham	◎ Target	Oppenheimer	Christopher Glynn ★★★★☆ #922	Outperform	$130.00→ $115.00-11.5%
Oct 08 14:14 UTC	FLUT Flutter Entertainment	◎ Target	Wedbush	Matthew McCartney not yet tracked	Outperform	$126.00→ $110.00-12.7%
Oct 08 14:14 UTC	CWH Camping World	◎ Target	KeyCorp	Noah Zatzkin ★★☆☆☆ #2335	Overweight	$9.00→ $8.00-11.1%
Oct 08 14:14 UTC	BIIB Biogen	◎ Target	Royal Bank Of Canada	Brian Abrahams ★★☆☆☆ #2565	Outperform	$260.00→ $256.00-1.5%
Oct 08 14:14 UTC	AYI Acuity	◎ Target	Oppenheimer	Christopher Glynn ★★★★☆ #922	Outperform	$440.00→ $415.00-5.7%
Oct 08 14:14 UTC	AUR Aurora Innovation	◎ Target	Oppenheimer	Colin Rusch ★★☆☆☆ #2584	Outperform	$15.00→ $16.00+6.7%
Oct 08 14:14 UTC	ACAD ACADIA Pharmaceuticals	◎ Target	Royal Bank Of Canada	Brian Abrahams ★★☆☆☆ #2565	Outperform	$37.00→ $36.00-2.7%
Oct 08 13:14 UTC	W Wayfair	◎ Target	Robert W. Baird	Colin Sebastian ★★★★☆ #372	Neutral	$116.00→ $117.00+0.9%
Oct 08 13:14 UTC	STZ Constellation Brands	◎ Target	Royal Bank Of Canada	Nik Modi ★★★☆☆ #1965	Outperform	$185.00→ $182.00-1.6%
Oct 08 13:14 UTC	SAIL SailPoint	◎ Target	Robert W. Baird	Shrenik Kothari ★★★★☆ #652	Outperform	$22.00→ $25.00+13.6%
Oct 08 13:14 UTC	RUN Sunrun	◎ Target	The Goldman Sachs Group	Brian Lee not yet tracked	Buy	$13.00→ $11.00-15.4%
Oct 08 13:14 UTC	MMED MiniMed Group	◎ Target	Mizuho	Anthony Petrone ★★★★☆ #665	Outperform	$26.00→ $28.00+7.7%
Oct 08 13:14 UTC	MCD McDonald's	◎ Target	Sanford C. Bernstein	Danilo Gargiulo ★★★☆☆ #2109	Market Perform	$295.00→ $250.00-15.3%
Oct 08 13:14 UTC	LW Lamb Weston	◎ Target	Stephens	Pooran Sharma ★★★★☆ #430	Equal Weight	$50.00→ $55.00+10.0%
Oct 08 13:14 UTC	LEVI Levi Strauss & Co.	◎ Target	Bank of America	Christopher Nardone ★★★☆☆ #1176	Buy	$27.00→ $25.00-7.4%
Oct 08 13:14 UTC	H Hyatt Hotels	◎ Target	Mizuho	Ben Chaiken not yet tracked	Outperform	$221.00→ $222.00+0.5%
Oct 08 13:14 UTC	FSLR First Solar	◎ Target	The Goldman Sachs Group	Brian Lee not yet tracked	Buy	$310.00→ $272.00-12.3%
Oct 08 13:14 UTC	AR Antero Resources	◎ Target	Mizuho	Nitin Kumar not yet tracked	Outperform	$57.00→ $51.00-10.5%
Oct 08 12:14 UTC	VLO Valero Energy	◎ Target	Mizuho	Nitin Kumar not yet tracked	Neutral	$300.00→ $434.00+44.7%
Oct 08 12:14 UTC	STZ Constellation Brands	◎ Target	Morgan Stanley	Dara Mohsenian ★★★★☆ #887	Equal Weight	$158.00→ $145.00-8.2%
Oct 08 12:14 UTC	STZ Constellation Brands	◎ Target	Needham & Company LLC	Gerald Pascarelli ★★☆☆☆ #2262	Buy	$185.00→ $150.00-18.9%
Oct 08 12:14 UTC	PFE Pfizer	◎ Target	Cantor Fitzgerald	Carter Gould ★★☆☆☆ #2287	Neutral	$27.00→ $28.00+3.7%
Oct 08 12:14 UTC	PBF PBF Energy	◎ Target	Mizuho	Nitin Kumar not yet tracked	Neutral	$65.00→ $89.00+36.9%
Oct 08 12:14 UTC	P Everpure	◎ Target	Needham & Company LLC	Matthew Calitri ★★★☆☆ #1858	Buy	$150.00→ $185.00+23.3%
Oct 08 12:14 UTC	NFLX Netflix	◎ Target	Morgan Stanley	Sean Diffley ★★☆☆☆ #2418	Overweight	$83.00→ $80.00-3.6%
Oct 08 12:14 UTC	MRK Merck & Co., Inc.	◎ Target	Cantor Fitzgerald	Carter Gould ★★☆☆☆ #2287	Neutral	$120.00→ $145.00+20.8%
Oct 08 12:14 UTC	MPC Marathon Petroleum	◎ Target	Mizuho	Nitin Kumar not yet tracked	Neutral	$304.00→ $457.00+50.3%
Oct 08 12:14 UTC	LLY Eli Lilly and Company	◎ Target	Cantor Fitzgerald	Carter Gould ★★☆☆☆ #2287	Overweight	$1,410.00→ $1,440.00+2.1%
Oct 08 12:14 UTC	IT Gartner	◎ Target	Morgan Stanley	Toni Kaplan ★★★☆☆ #1132	Equal Weight	$177.00→ $182.00+2.8%
Oct 08 12:14 UTC	IOVA Iovance Biotherapeutics	◎ Target	Robert W. Baird	Colleen Kusy not yet tracked	Neutral	$6.00→ $11.00+83.3%
Oct 08 12:14 UTC	HCSG Healthcare Services Group	◎ Target	Robert W. Baird	Andrew Wittmann ★★★★☆ #340	Neutral	$26.00→ $24.00-7.7%
Oct 08 12:14 UTC	ELMT Elmet Group	◎ Target	Needham & Company LLC	James Ricchiuti ★★★☆☆ #1398	Buy	$25.00→ $28.00+12.0%
Oct 08 12:14 UTC	DINO HF Sinclair	◎ Target	Mizuho	Nitin Kumar not yet tracked	Neutral	$85.00→ $119.00+40.0%
Oct 08 12:14 UTC	CVI CVR Energy	◎ Target	Mizuho	Nitin Kumar not yet tracked	Underperform	$29.00→ $52.00+79.3%
Oct 08 12:14 UTC	BMY Bristol Myers Squibb	◎ Target	Cantor Fitzgerald	Carter Gould ★★☆☆☆ #2287	Neutral	$59.00→ $53.00-10.2%
Oct 08 12:14 UTC	AVBP ArriVent BioPharma	◎ Target	HC Wainwright	Robert Burns ★★★☆☆ #1778	Buy	$47.00→ $27.00-42.6%
Oct 08 12:14 UTC	APLD Applied Digital	◎ Target	Needham & Company LLC	John Todaro ★★☆☆☆ #2557	Buy	$83.00→ $70.00-15.7%
Oct 08 12:14 UTC	ABBV AbbVie	◎ Target	Cantor Fitzgerald	Carter Gould ★★☆☆☆ #2287	Overweight	$285.00→ $290.00+1.8%
Oct 08 11:14 UTC	OTB On the Beach Group	◎ Target	Berenberg Bank	firm only	Buy	GBX 280→ GBX 240-14.3%
Oct 08 11:14 UTC	HWG Harworth Group	◎ Target	Berenberg Bank	firm only	Hold	GBX 195→ GBX 187-4.1%
Oct 08 00:12 UTC	ZYME Zymeworks	◎ Target	Truist Financial	Gregory Renza ★★☆☆☆ #2638	Buy	$32.00→ $34.00+6.2%
Oct 08 00:12 UTC	ZS Zscaler	◎ Target	Jefferies Financial Group	Joseph Gallo ★★★★★ #204	Buy	$220.00→ $250.00+13.6%
Oct 08 00:12 UTC	ZS Zscaler	◎ Target	Scotiabank	Patrick Colville ★★★★☆ #587	Sec→ r Outperform	$240.00→ $255.00+6.2%
Oct 08 00:12 UTC	ZS Zscaler	◎ Target	Citigroup	Fatima Boolani ★★★★☆ #839	Buy	$205.00→ $245.00+19.5%
Oct 08 00:12 UTC	ZS Zscaler	◎ Target	UBS Group	Roger Boyd ★★★★☆ #541	Buy	$225.00→ $250.00+11.1%

🔒 38 more rating changes on this page — plus filtering by our own analyst accuracy.

A free account unlocks the full daily feed.

Frequently Asked Questions

What are analyst rating changes?

An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.

How is this feed different from other rating trackers?

Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.

How often is the rating-changes feed updated?

The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.

Do analyst upgrades and price-target increases mean I should buy?

No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.

Analyst Rating Changes — Upgrades, Downgrades & Price Targets

Latest Price-Target Changes

Frequently Asked Questions

Welcome to 13Foresight!